Your browser doesn't support javascript.
loading
The Performance of the Agility System for Interferon Gamma Release Assay Using QuantiFERON TB Gold In-Tube Assay
Article in English | WPRIM (Western Pacific) | ID: wpr-741140
Responsible library: WPRO
ABSTRACT

BACKGROUND:

As stated in ‘The Action Strategy for Tuberculosis-Free Korea,’ last March, high-throughput, large-scale analytical instruments for interferon gamma release assays (IGRA) are demanded by many clinical laboratories using the QuantiFERON-TB Gold In-Tube assay (Cellestis/Qiagen, Australia). Agility (Dynex Technologies, USA) is an automated high-throughput enzyme linked immunosorbent assay analyser. The present study aimed to evaluate its accuracy and speed.

METHODS:

Pooled plasma was prepared using samples obtained after IGRA testing. Analyses of precision, linearity, cut-off evaluation, and comparison with conventional methods were performed for multiple Agility instruments according to the Clinical and Laboratory Standards Institute EP5-A3, EP6-A, EP9-A3 and EP12-A2 guidelines. The turnaround time and throughput were also analysed.

RESULTS:

The coefficient of variation range was 2.48%–4.0%, 7.01%–11.17%, and 9.69%–14.84% for the repeatability, between-run precision, and between-day precision analyses, respectively. The linearity ranged from 0 to 10.541. Comparison analysis presented a high concordance of Agility with the conventional instrument, DS2 (Dynex Technologies), and manual method for IGRA. The cut-off value of 0.35 IU/mL was well compatible with the C50. It was identified that the C50±20% contained the C5–C95 interval. The average turnaround time was 3.84 hours, from the submission of pre-treated samples to the reporting of results. The throughput was determined to be 290 tests during a routine working time of 8 hours.

CONCLUSIONS:

Agility showed high precision, linearity, concordance, and had a 2.5 times faster throughput than with the conventional and manual method. It could be useful for large-scale IGRA testing in latent tuberculosis infection screening project. Samples within C50±20% are suspected to show relatively low reporducible results of high inversion between postivie and negative.
Subject(s)

Full text: Available Health context: Neglected Diseases / SDG3 - Target 3.3 End transmission of communicable diseases Health problem: Neglected Diseases / Tuberculosis / Tuberculosis Database: WPRIM (Western Pacific) Main subject: Plasma / Enzyme-Linked Immunosorbent Assay / Mass Screening / Interferons / Latent Tuberculosis / Interferon-gamma Release Tests / Methods Type of study: Practice guideline / Screening study Language: English Journal: Journal of Laboratory Medicine and Quality Assurance Year: 2019 Document type: Article
Full text: Available Health context: Neglected Diseases / SDG3 - Target 3.3 End transmission of communicable diseases Health problem: Neglected Diseases / Tuberculosis / Tuberculosis Database: WPRIM (Western Pacific) Main subject: Plasma / Enzyme-Linked Immunosorbent Assay / Mass Screening / Interferons / Latent Tuberculosis / Interferon-gamma Release Tests / Methods Type of study: Practice guideline / Screening study Language: English Journal: Journal of Laboratory Medicine and Quality Assurance Year: 2019 Document type: Article
...